Relmada Therapeutics RLMD
NASDAQ RLMD
$3.21 +0.00 (+0.16%)
As of: Oct 22, 2026 · 1:21 PM EDT

Relmada Therapeutics (RLMD) Change in Receivables (2019 - 2023)

Updated

Relmada Therapeutics (RLMD) posted Change in Receivables of -$512,432 for Q1 2023.

Analysis

Relmada Therapeutics (RLMD) Change in Receivables (2019 - 2023) Analysis & Trends

For FY2022, Relmada Therapeutics' Change in Receivables came in at $512,432.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,165.98 Bn 1,134.57 Bn 19.71 Bn -
2 Johnson & Johnson 643.66 Bn 563.53 Bn 17.30 Bn -188.00 Mn
3 AbbVie 500.95 Bn 474.06 Bn 12.70 Bn 1.37 Bn
4 Merck 358.08 Bn 312.45 Bn 12.21 Bn -
5 Novartis Ag 301.84 Bn 265.83 Bn 11.24 Bn -
6 Astrazeneca 267.25 Bn 240.94 Bn 12.86 Bn -
7 Amgen 241.42 Bn 196.81 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn 333.00 Mn
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn -
10 Relmada Therapeutics 360.73 Mn -197.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -512,432.00
Sep 30, 2022 -42,234.00
Jun 30, 2022 -23,220.00
Mar 31, 2022 -20,923.00
Dec 31, 2021 -20,490.00
Sep 30, 2021 -20,068.00
Jun 30, 2021 -19,652.00
Mar 31, 2021 -19,247.00
Dec 31, 2020 -18,849.00
Sep 30, 2020 -18,460.00
Jun 30, 2020 -18,078.00
Mar 31, 2020 -17,704.00
Mar 31, 2019 -16,285.00
API Access

Relmada Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=RLMD&period=max&api_key=YOUR_API_KEY